UNSPSC 51284714: Sulfadiasulfone sodium

This classification denotes a sulfone anti-infective agent with the molecular formula C14H14N3O5S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQ3M2Y4BU3, chemically known as 4, 4-diaminodiphenylsulfone-2-n-acetylsulfonamide, sodium but more generally known as acetosulfone sodium, which bears US NIH Compound Identifier 31400. European Medicines Agency schedules Sulfadiasulfone sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10694MIG.

The term SULFADIASULFONE SODIUM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). Most nations, for tariff and trade purposes, schedule sulfadiasulfone sodium under HS 29350090. SMILES: CC(=O)[N-]S(=O)(=O)C1CC(CCC1S(=O)(=O)C2CCC(CC2)N)N.[NA+].

UNSPSC 51284714 Sulfadiasulfone sodium is a Commodity code that nominally names a specific pharmaceutical compound, but recent state and local solicitations tagged with this code show little activity directly aligned with sulfadiasulfone sodium procurement. Instead, the tagged opportunities reflect broader pharmaceutical and medical supply purchasing — generic pharmaceuticals, over-the-counter products, naloxone, and medical first aid supplies for emergency response and public health programs. The disconnect suggests either metadata misalignment in the source system or that sulfadiasulfone sodium procurement, if it occurs in state and local markets, is too sparse to register in current notices. State and local issuing bodies using pharmaceutical commodity codes include health departments, county public health agencies (such as Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). When pharmaceutical solicitations do post, they span multiple issuing-body types and often reach across state lines through cooperative purchasing vehicles.

Recent activity shows geographic concentration in Minnesota, Texas, and Florida, with the largest formal procurements anchored to cooperative purchasing arrangements serving multiple jurisdictions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, serving state and local facilities across Minnesota and Oregon through authorized wholesalers. The Texas Health and Human Services Commission issued a Request for Information on direct-to-manufacturer prescription programs (HHS0017013, due April 3, 2026) to inform future pharmacy benefit strategy. Seminole County, Florida issued an IFB for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2023), seeking 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries. The City of Tampa issued an IFB for medical and first aid supplies for the Fire Department Rescue Division (26P00145, due March 13, 2026) with an estimated contract value of $700,000, restricted to certified Small Local Business Enterprises. The code shows no current activity that directly evidences sulfadiasulfone sodium procurement at the state and local level.